Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.

MLA

Mackinnon, Sabrina R., et al. “Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.” Frontiers in Chemistry, vol. 10, May 2022, p. 844598. EBSCOhost, https://doi.org/10.3389/fchem.2022.844598.

APA

Mackinnon, S. R., Bezerra, G. A., Krojer, T., Szommer, T., von Delft, F., Brennan, P. E., & Yue, W. W. (2022). Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening. Frontiers in Chemistry, 10, 844598. https://doi.org/10.3389/fchem.2022.844598

Chicago

Mackinnon, Sabrina R, Gustavo A Bezerra, Tobias Krojer, Tamas Szommer, Frank von Delft, Paul E Brennan, and Wyatt W Yue. 2022. “Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.” Frontiers in Chemistry 10 (May): 844598. doi:10.3389/fchem.2022.844598.